Pharmaceuticals News and Research

RSS

Human Melanoma Research Team pursuing identification of anti-tumor prognostic markers and drugs

The constant increase in the rate of cutaneous melanoma over recent years and its resistance to anti-tumour pharmaceutical drugs has meant that the study of cutaneous melanoma is one of the greatest scientific challenges in the field of cancer. The Human Melanoma research team at the University of the Basque Country (UPV/EHU) is focusing on this study.

2 Dec 2009

NPS awarded two multi-year contracts to provide Alternative Sampling and Marketing programs

Following a highly competitive evaluation process, National Patient Services (NPS) - A Triplefin Company has been awarded two multi-year contracts to provide Alternative Sampling and Marketing programs for two Fortune 50 Pharmaceutical Manufacturing companies.

2 Dec 2009

Educational resource guide about pharmaceutical industry practices released

The educational resource, "The Value of Medicine, Improving Health... Improving Life," created by Lilly USA (NYSE: LLY), is now available at www.lillyforbetterhealth.com/value_of_medicine.jsp. The booklet supports Lilly's commitment to providing "Answers That Matter" and encourages an open dialogue with patients, providers, payers and the public about pharmaceutical industry practices.

2 Dec 2009

SynBIA formed to address the emergence of synthetic biology industry and to promote its potential

To address the emergence of the synthetic biology industry and to promote its potential, a group of individuals and companies announced the formation of the Synthetic Biology Industry Association (SynBIA) in Cambridge, Massachusetts last week.

2 Dec 2009

Roche announces results of phase III taspoglutide study in diabetes patients

Ipsen, an innovation-driven global specialty pharmaceutical group, today announced that its partner Roche has disclosed the results of the second and third of eight T-emerge phase III studies in patients with diabetes for taspoglutide, the first human once weekly glucagon-like peptide-1 (GLP-1) analogue originating from Ipsen’s research and developed by Roche.

2 Dec 2009

Future likely to witness improved therapies and novel drugs to treat lifestyle disorders

Increasing genomic knowledge will lead to the development of improved therapies to treat lifestyle disorders. In the near future, the European lifestyle disorders therapeutics market is set to witness enhanced therapies and novel drugs to treat such conditions and reduce the risk of co-morbidities.

2 Dec 2009

Occult lesions identified with BSGI can be localized using multi-modality imaging for needle biopsy

Dr. Jocelyn Rapelyea, Associate Director of Breast Imaging and Intervention at George Washington University Medical Center in Washington, D.C., demonstrated how occult lesions identified with Breast-Specific Gamma Imaging (BSGI) can be localized utilizing multi-modality imaging for needle biopsy as well, as for pre-operative localization today at the annual meeting of the Radiological Society of North America (RSNA).

2 Dec 2009

Burrill Biotech Select Index manages to claw back almost half the value it lost in October

The Burrill Biotech Select Index managed to claw back almost half the value it lost in October. The Select's gain of 4.5 percent mirrored what was also an excellent month for the general markets with the Dow up 6.5 percent and the NASDAQ up 4.8 percent in value.

2 Dec 2009

Affordable Health Care Act to increase number of insured Americans by 36 million

According to Fitch Ratings' Fall U.S. Healthcare Sector Legislative and Regulatory Register, the Affordable Health Care for America Act of 2009 (H.R. 3962) passed by the House of Representatives on Nov. 7, 2009 will generally increase the number of insured Americans by 36 million through individual and employer mandates, coupled with a number of subsidies offered to lower-income individuals and smaller employers.

2 Dec 2009

70% of 350 US physicians will increase the use niacin for patients, says report

Sermo (http://www.sermo.com), the world's largest online physician's community, today announced the results of a new report indicating that 70% of 350 US physician respondents would increase their use of niacin based on results from the ARBITER 6-HALTS trial.

2 Dec 2009

BSGI effective in detecting malignant or high-risk lesions in patients with negative mammographic findings

Breast-Specific Gamma Imaging (BSGI) significantly contributes to the detection of malignant or high-risk lesions in patients with negative or indeterminate mammographic findings, according to results of a multicenter study presented today at the annual meeting of the Radiological Society of North America (RSNA).

2 Dec 2009

FDA approves Schering-Plough's New Drug Application for ZEGERID OTC capsules

Santarus, Inc., a specialty biopharmaceutical company, today announced that the U.S. Food and Drug Administration (FDA) has approved Schering-Plough HealthCare Products, Inc.’s, New Drug Application (NDA) for ZEGERID OTC™ Capsules (omeprazole/sodium bicarbonate) with a dosage strength of 20 mg of omeprazole for over-the-counter (OTC) treatment of frequent heartburn.

2 Dec 2009

Results from second Phase III placebo controlled study of EXPAREL announced

Pacira Pharmaceuticals, Inc., announced today that its second Phase III placebo controlled study of EXPAREL(TM) (DepoBupivacaine) met its primary endpoint.

2 Dec 2009

J&JPRD submits an NDA for tapentadol ER tablets

Johnson & Johnson Pharmaceutical Research & Development, L.L.C. announced today that it has submitted a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) for tapentadol extended release (ER) tablets, an investigational oral analgesic for the management of moderate to severe chronic pain in patients 18 years of age or older.

2 Dec 2009

DiaMedica to acquire all issued and outstanding shares of Sanomune

DiaMedica Inc. (TSX VENTURE:DMA)("Diamedica"), a biopharmaceutical company that has discovered and is developing a novel approach to treating diabetes, announces it has entered into a non-binding letter of intent to acquire all of the issued and outstanding shares of Sanomune Inc.

2 Dec 2009

Galenea and Otsuka Pharmaceutical extend their research and development collaboration

Galenea Corp. and Otsuka Pharmaceutical Co., Ltd. announced today the further extension of their research and development collaboration through 2011. This latest extension increases the collaboration term to seven years and brings the total committed funding to approximately $90 million.

2 Dec 2009

Canadians with hemophilia A can use new treatment option, XYNTHA

Canadians with hemophilia A - a rare, inherited blood-clotting disorder - now have a new treatment option with the introduction of XYNTHA(TM), a recombinant factor VIII product for both the control and prevention of bleeding episodes and surgical prophylaxis.

2 Dec 2009

Study of Acetadote Injection as a cost-saving treatment for acetaminophen poisoning published

Cumberland Pharmaceuticals Inc. announced today that an independently conducted study of Acetadote (acetylcysteine) Injection, or intravenous N-acetylcysteine, as a cost-saving treatment for acetaminophen poisoning was published in Volume 12, Number 4 of the peer-reviewed Journal of Medical Economics, distributed in December.

2 Dec 2009

Veeco Instruments introduces ScanAsyst and PeakForce QNM scan modes

Veeco Instruments Inc., the leading provider of atomic force microscope (AFM) instrumentation to the Research and Industrial communities, announced today the introduction of two patent-pending AFM scan modes, ScanAsyst™ and PeakForce™ QNM™.

2 Dec 2009

Ohr Pharmaceutical to present interim data from ongoing Phase II clinical trial of OHR/AVR118

Ohr Pharmaceutical Inc., announced that interim data from the company's ongoing Phase II clinical trial of OHR/AVR118 for the treatment of Cachexia, will be presented at the 5th annual meeting of the Society on Cachexia and Wasting Disorders (SCWD), which will be held in Barcelona December 5 - December 8, 2009.

2 Dec 2009

Pharmaceuticals News and Research

Human Melanoma Research Team pursuing identification of anti-tumor prognostic markers and drugs

NPS awarded two multi-year contracts to provide Alternative Sampling and Marketing programs

Educational resource guide about pharmaceutical industry practices released

SynBIA formed to address the emergence of synthetic biology industry and to promote its potential

Roche announces results of phase III taspoglutide study in diabetes patients

Future likely to witness improved therapies and novel drugs to treat lifestyle disorders

Occult lesions identified with BSGI can be localized using multi-modality imaging for needle biopsy

Burrill Biotech Select Index manages to claw back almost half the value it lost in October

Affordable Health Care Act to increase number of insured Americans by 36 million

70% of 350 US physicians will increase the use niacin for patients, says report

BSGI effective in detecting malignant or high-risk lesions in patients with negative mammographic findings

FDA approves Schering-Plough's New Drug Application for ZEGERID OTC capsules

Results from second Phase III placebo controlled study of EXPAREL announced

J&JPRD submits an NDA for tapentadol ER tablets

DiaMedica to acquire all issued and outstanding shares of Sanomune

Galenea and Otsuka Pharmaceutical extend their research and development collaboration

Canadians with hemophilia A can use new treatment option, XYNTHA

Study of Acetadote Injection as a cost-saving treatment for acetaminophen poisoning published

Veeco Instruments introduces ScanAsyst and PeakForce QNM scan modes

Ohr Pharmaceutical to present interim data from ongoing Phase II clinical trial of OHR/AVR118

Ultimate guide to the essential tools for the characterization of proteins, polymers and nanoparticles eBook

Latest eBooks

A practical guide to lipid nanoparticle formulation and resizing

Editorial Focus eBook - Spatial and single-cell omics (1st edition)

Industry Focus eBook - Analytical Chemistry (3rd edition)

Industry Focus eBook - Microbiome (1st edition)

Improving healthcare sustainability through carbon data

A New Approach to Preventing Bladder Cancer Recurrence

Bringing real-time analytics to downstream bioprocess monitoring